Related Experiment Video
Updated: Jan 9, 2026

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
Critical care primary services are associated with reduced midazolam use in the intensive care unit
Konstantin G Nestoiter1, Kristin Feick2, Kristen Looney2
1Department of Critical Care Medicine, University of Pittsburgh Medical Center Harrisburg, Harrisburg, PA 17101, United States. konstantin.nestoiter@gmail.com.
Background:
Analgesia and sedation are commonly prescribed therapies within the intensive care unit (ICU) for patients receiving mechanical ventilation. Current guidelines recommend utilizing an analgesia-first approach to initially reach appropriate pain control, while potentially achieving sedation goals concurrently. Our system employs a guideline-based ICU sedation order-set that features an electronic medical record (EMR) integrated ICU checklist that combines analgesia and sedation.
Aim:
To identify systems-based factors that are associated with the use of continuous midazolam infusion administration in mechanically ventilated patients.
Methods:
We extracted EMR data from patients who received mechanical ventilation between January 1, 2021, and December 31, 2023. Subjects included were 18 years or older who received mechanical ventilation. "R" version 4.3.2 was used for data processing and statistical analysis. We performed a multivariable regression analysis to predict the administration of a continuous midazolam infusion with modified Sequential Organ Failure Assessment score, Charlson comorbidity index, and critical care medicine (CCM) primary service.
Results:
Of 3805 patients that underwent mechanical ventilation, 62% were male, with a mean age of 66.9 years. 3429 patients were treated by a provider team with a CCM attending, and 376 patients were managed by a non-CCM primary team with CCM consultative services. A midazolam infusion was used in 187 of 3429 (5%) patients with CCM as primary and in 166 of 376 (56%) patients with non-CCM primary (χ 2 598.23, P < 0.001). Of the patients who received continuous midazolam, 117 (21%) died vs 236 (7%) survived hospitalization. Continuous midazolam was associated with more days with coma and more days with delirium (P < 0.0001).
Conclusion:
Continuous midazolam infusion was more likely in patients admitted to the ICU under an open unit with a non-CCM physician with an intensivist consult available, despite guided order-sets and checklists integrated into the EMR.
More Related Videos
04:56In Vitro Method to Control Concentrations of Halogenated Gases in Cultured Alveolar Epithelial Cells
Published on: October 23, 2018
05:39Author Spotlight: A Non-Intubated Video-Assisted Thoracoscopic Surgery with Multimodal Analgesia and Sevoflurane Inhalation Anesthesia
Published on: May 26, 2023
Related Concept Videos
Parenteral Anesthetics: Overview
Inhalational Anesthetics: Overview
Acute Coronary Syndrome IV: Interprofessional Care
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
CNS Depressants: Barbiturates and Benzodiazepines
General Anesthesia: Overview
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...